State of Wisconsin Investment Board
ATXS

State of Wisconsin Investment Board’s Astria Therapeutics ATXS Stock Holding History

State of Wisconsin Investment Board’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,322
Closed -$137K – 2252
2024
Q4 		$137K Sell
15,322
-1,635
-10% -$17.4K ﹤0.01% 2175
2024
Q3 		$187K Sell
16,957
-7,672
-31% -$85.3K ﹤0.01% 2168
2024
Q2 		$224K Buy
+24,629
New +$240K ﹤0.01% 2124

Other funds holding ATXS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

State of Wisconsin Investment Board's ATXS Position: Q1 2025 in Review

State of Wisconsin Investment Board sold out of Astria Therapeutics (ATXS) in Q1 2025, closing a stake of 15,322 shares — an estimated $137K sold.

State of Wisconsin Investment Board first reported a position in ATXS in Q2 2024 and held it in 3 quarters. The position peaked at $224K in Q2 2024. 115 funds tracked by Wall St. Rank hold ATXS as of Q1 2025.

  • State of Wisconsin Investment Board reported no remaining Astria Therapeutics position as of Q1 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 15,322 Astria Therapeutics shares in Q1 2025, an estimated $137K.
  • State of Wisconsin Investment Board first reported a position in Astria Therapeutics in Q2 2024 and held it in 3 quarters.
  • State of Wisconsin Investment Board's Astria Therapeutics position peaked at $224K in Q2 2024.
  • 115 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2025, filed 15 May 2025.